by ClorDiSys Solutions Inc
ClorDiSys ultraviolet light (UV-C) methodology and equipment is the first practical approach to improving the situation. These solutions allow for the safer transfer of items into a clean-room, disinfecting incoming pallets, supplies, and equipment, or simply disinfecting communal spaces after use.
by Rentschler Biopharma
New facility at the existing facility in Milford, MA, USA will significantly expand cGMP manufacturing capabilities and accelerate the clinical and commercial supply of vital biopharmaceuticals
by Picocyl
As new and novel drug therapies are developed to address areas where conventional medicines are limited, drug delivery innovators, designers and manufacturers have turned to Picocyl for its unique, patented power solutions for drug and implant delivery systems.
by Tonix Pharmaceuticals
Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs
by California Healthline
In December, the Food and Drug Administration issued a thorough inspection report on PharMEDium’s Tennessee plant that resulted in a pause in pharmaceutical production, until otherwise permitted. PharMEDium, one of the nation’s largest compounding pharmacy companies, is owned by AmerisourceBergen. It supplies medications to about 77% of hospitals nationwide.
by Cleanroom Connect Editor
Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.
by Cleanroom Connect Editor
Researchers at ITMO University developed a new approach for obtaining non-toxic magnetic photonic crystals, expanding their applications from mainly photonics to biomedicine. Nanospheres made with the new method may be used for designing drugs to fight thrombosis and cancer.
by Fosun Pharmaceutical
Fosun Pharmaceutical to buy French drug distributor Tridem. The pharmaceuticals arm of Chinese conglomerate Fosun International has agreed to buy Tridem, an Africa-focused French drug distributor, for up to €63m ($73.1m).